Edwin Urrutia
About Edwin Urrutia
Edwin Urrutia serves as Vice President at Travere Therapeutics and has held various leadership roles in multiple companies, including Co-Founder and Chief Operating Officer at Pyros Pharmaceuticals. He holds a Bachelor's Degree in Finance from Northeastern University and has extensive experience in the finance and pharmaceutical sectors.
Work at Travere Therapeutics
Edwin Urrutia serves as Vice President at Travere Therapeutics, a position he has held since 2013. In this role, he is involved in strategic decision-making and operational management within the company. Travere Therapeutics focuses on developing and delivering innovative therapies for rare diseases, and Urrutia's leadership contributes to advancing the company's mission.
Current Roles in the Pharmaceutical Industry
In addition to his role at Travere Therapeutics, Edwin Urrutia is also the Co-Founder and Chief Operating Officer at Pyros Pharmaceuticals, a position he has held since 2017. He co-founded Phoenixus AG in 2014, where he continues to contribute as a Co-Founder. Urrutia has extensive experience in the pharmaceutical sector, demonstrating a commitment to innovation and growth in the industry.
Experience at Piper Sandler
Edwin Urrutia has been an Analyst at Piper Sandler since 2011, accumulating over 13 years of experience in financial analysis and investment banking. His work at Piper Sandler involves providing insights and analysis that support investment decisions and strategic initiatives for clients in various sectors.
Education and Expertise
Edwin Urrutia earned a Bachelor’s Degree in Finance from Northeastern University. His educational background provides a strong foundation for his roles in finance and the pharmaceutical industry, equipping him with the necessary skills to navigate complex financial landscapes and contribute to strategic business decisions.